Sfoglia per AUTORE
CATHELINEAU X
Collezione AOU Città della Salute di Torino

  

Items : 7

The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):244-251. doi: 10.1016/j.clgc.2023.11.006. Epub 2023 Nov 17.
2024
AOU Città della Salute di Torino

Montorsi F; Scuderi S; Mattei A; Karnes RJ; Afferi L; Fankhauser CD; Cathelineau X; Sanchez-Salas R; Berchiche W; Gallina S; Antonelli A; Bianchi A; Shariat SF; Van den Bergh RCN; Kowalczyk K; Malkiewicz B; Chiu PK; Hermanns T; Affentranger A; Grogg JB; Dariane C; Magli A; Moro FD; Zattoni F; Olivier J; Puche-Sanz I; Montefusco G; Ploussard G; Filippini C; et alii...

Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Oct;74(5):581-589. doi: 10.23736/S2724-6051.20.04160-0. Epub 2021 Jan 13.
2022
AOU Città della Salute di Torino

Marra G; Laguna MP; Walz J; Pavlovich CP; Bianco F; Gregg J; Lebastchi AH; Lepor H; Macek P; Rais-Bahrami S; Robertson C; Rukstalis D; Salomon G; Ukimura O; Abreu AL; Barbe Y; Cathelineau X; Gandaglia G; George AK; Gomez Rivas J; Gupta RT; Lawrentschuk N; Kasivisvanathan V; Lomas D; Malavaud B; Margolis D; Matsuoka Y; Mehralivand S; Moschini M; et alii...

Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance. in European urology focus / Eur Urol Focus. 2022 May;8(3):701-709. doi: 10.1016/j.euf.2021.04.008. Epub 2021 Apr 27.
2022
AOU Città della Salute di Torino

Cathelineau X; Sanchez-Salas R; Cathala N; Macek P; Gontero P; van den Bergh RCN; van Melick HHE; Filippini C; Moschini M; Tourinho-Barbosa R; Oreggia D; Soeterik T; Marra G;

Focal High-Intensity Focused Ultrasound vs. Active Surveillance for ISUP Grade 1 Prostate Cancer: Medium-Term Results of a Matched-Pair Comparison. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2022 Dec;20(6):592-604. doi: 10.1016/j.clgc.2022.06.009. Epub 2022 Jun 30.
2022
AOU Città della Salute di Torino

Pasquali C; Macek P; Cathala N; Gontero P; van den Bergh RC; van Melick HH; Filippini C; Stabile A; Moschini M; Tourinho-Barbosa R; Oreggia D; Soeterik T; Marra G; Sanchez-Salas R; Cathelineau X;

Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer. in European urology oncology / Eur Urol Oncol. 2022 Dec;5(6):722-725. doi: 10.1016/j.euo.2022.04.001. Epub 2022 Jun 15.
2022
AOU Città della Salute di Torino

Carando R; Pradere B; Contieri R; Hurle R; Aziz A; Maier E; Bajeot AS; Roumiguié M; Roghmann F; Albisinni S; Mattei A; Teoh JY; Chierigo F; Borghesi M; Ammiwala M; Hendricksen K; Cathelineau X; Arora A; Sanchez Salas R; Xylinas E; Soria F; Ma?kiewicz B; Krajewski W; Antonelli A; Tafuri A; Simeone C; Mondini F; Zamboni S; Rink M; et alii...

Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center. in International braz j urol : official journal of the Brazilian Society of Urology / Int Braz J Urol. 2020 Nov-Dec;46(6):984-992. doi: 10.1590/S1677-5538.IBJU.2019.0682.
2020
AOU Città della Salute di Torino

Sivaraman A; Marra G; Stabile A; Mombet A; Macek P; Lanz C; Cathala N; Moschini M; Carneiro A; Sanchez-Salas R; Cathelineau X;

2019
AOU Città della Salute di Torino

Cathelineau X; Tourinho-Barbosa R; Sivaraman A; Walz JC; Gontero P; Marra G; Sanchez-Salas R;